Denali Therapeutics Inc.
PROGRANULIN VARIANTS
Last updated:
Abstract:
Provided herein are progranulin variants and fusion proteins that comprise a progranulin variant and an Fc polypeptide. Methods of using such proteins to treat progranulin-associated disorders (e.g., a neurodegenerative disease, such as frontotemporal dementia (FTD)) are also provided herein.
Status:
Application
Type:
Utility
Filling date:
17 Mar 2022
Issue date:
7 Jul 2022